BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2175370)

  • 1. Renal metabolism of angiotensin I and II.
    Erdös EG; Skidgel RA
    Kidney Int Suppl; 1990 Nov; 30():S24-7. PubMed ID: 2175370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies.
    Skidgel RA; Erdös EG
    Peptides; 2004 Mar; 25(3):521-5. PubMed ID: 15134871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the metabolism of substance P and neurotensin by human angiotensin I converting enzyme and "enkephalinase".
    Skidgel RA
    Prog Clin Biol Res; 1985; 192():371-8. PubMed ID: 2417254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging role of angiotensin-converting enzyme-2 in the kidney.
    Burns KD
    Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):116-21. PubMed ID: 17293686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Active metabolites derived from angiotensin II].
    Chansel D; Ardaillou R
    Nephrologie; 1998; 19(7):427-32. PubMed ID: 9857379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A scrutiny of the biochemical pathways from Ang II to Ang-(3-4) in renal basolateral membranes.
    Axelband F; Dias J; Miranda F; Ferrão FM; Barros NM; Carmona AK; Lara LS; Vieyra A
    Regul Pept; 2009 Nov; 158(1-3):47-56. PubMed ID: 19703499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
    J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11.
    Welches WR; Brosnihan KB; Ferrario CM
    Life Sci; 1993; 52(18):1461-80. PubMed ID: 8387132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin and bradykinin metabolism by peptidases identified in skeletal muscle.
    Ward PE; Russell JS; Vaghy PL
    Peptides; 1995; 16(6):1073-8. PubMed ID: 8532591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of peptidases in regulating vascular tonus].
    Orekhovich VN; Eliseeva IuE; Pavlikhina LV
    Vestn Akad Med Nauk SSSR; 1982; (9):34-8. PubMed ID: 6128841
    [No Abstract]   [Full Text] [Related]  

  • 12. Ultrastructural localization of angiotensin I-converting enzyme (EC 3.4.15.1) and neutral metalloendopeptidase (EC 3.4.24.11) in the proximal tubule of the human kidney.
    Schulz WW; Hagler HK; Buja LM; Erdös EG
    Lab Invest; 1988 Dec; 59(6):789-97. PubMed ID: 2848979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heme peroxidase-catalyzed iodination of human angiotensins and the effect of iodination on angiotensin converting enzyme activity.
    Bhuyan BJ; Mugesh G
    Inorg Chem; 2008 Aug; 47(15):6569-71. PubMed ID: 18598023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Properties and action specificity of carboxycathepsin (peptidyl dipepsidase) from bovine kidneys].
    Eliseeva IuE; Orekhovich VN; Pavlikhina LV
    Vopr Med Khim; 1976; 22(1):81-9. PubMed ID: 193290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local actions of angiotensin II: quantitative in vitro autoradiographic localization of angiotensin II receptor binding and angiotensin converting enzyme in target tissues.
    Chai SY; Allen AM; Adam WR; Mendelsohn FA
    J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S35-9. PubMed ID: 2438488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal handling of luteinizing hormone releasing hormone: a model for peptide transport and hydrolysis.
    Peterson DR; Skopicki HA; Zikos D; Flouret G
    Prog Clin Biol Res; 1988; 258():135-47. PubMed ID: 2837770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolyl endopeptidase purified from granulomatous inflammation in mice.
    Nozaki Y; Sato N; Iida T; Hara K; Fukuyama K; Epstein WL
    J Cell Biochem; 1992 Jul; 49(3):296-303. PubMed ID: 1644866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
    Gonzalez W; Beslot F; Laboulandine I; Fournié-Zaluski MC; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1996 Aug; 278(2):573-81. PubMed ID: 8768706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
    Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
    Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme 2 and the kidney.
    Soler MJ; Wysocki J; Batlle D
    Exp Physiol; 2008 May; 93(5):549-56. PubMed ID: 18223023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.